{"id":"https://openalex.org/W2389173754","doi":null,"title":"Progress in Sodium-glucose Co-transporter-2 Inhibitors:the New Target for Treatment of Type 2 Diabetes","display_name":"Progress in Sodium-glucose Co-transporter-2 Inhibitors:the New Target for Treatment of Type 2 Diabetes","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W2389173754","mag":"2389173754"},"language":"en","primary_location":{"id":"mag:2389173754","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTotal-SWCX200913053.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764952023","display_name":"Xiandai shengwu yixue jinzhan","issn_l":"1673-6273","issn":["1673-6273"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4361727479","host_organization_name":"Heilongjiang Red Cross Society","host_organization_lineage":["https://openalex.org/P4361727479"],"host_organization_lineage_names":["Heilongjiang Red Cross Society"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Xiandai shengwu yixue jinzhan","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057044310","display_name":"Shaoshun Li","orcid":"https://orcid.org/0000-0002-8431-6840","observed_orcids":["https://orcid.org/0000-0002-8431-6840"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Shaoshun Li","raw_affiliation_strings":["2 Egret Pharma"],"raw_orcid":"https://orcid.org/0000-0002-8431-6840","affiliations":[{"raw_affiliation_string":"2 Egret Pharma","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5057044310"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.38551006,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11140","display_name":"Natural Antidiabetic Agents Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9369999766349792},{"id":"https://openalex.org/keywords/sglt2","display_name":"SGLT2","score":0.8600000143051147},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9750000238418579},{"id":"https://openalex.org/keywords/renal-glucose-reabsorption","display_name":"renal glucose reabsorption","score":0.9819999933242798},{"id":"https://openalex.org/keywords/proximal-tubule","display_name":"proximal tubule","score":0.9169999957084656},{"id":"https://openalex.org/keywords/glucose-excretion","display_name":"glucose excretion","score":0.6179999709129333},{"id":"https://openalex.org/keywords/sglt1","display_name":"SGLT1","score":0.7149999737739563},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.6660000085830688},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.6859999895095825}],"concepts":[{"id":"https://openalex.org/C90466245","wikidata":"https://www.wikidata.org/wiki/Q7312490","display_name":"Renal glucose reabsorption","level":4,"score":0.9268398880958557},{"id":"https://openalex.org/C56906281","wikidata":"https://www.wikidata.org/wiki/Q4391435","display_name":"Reabsorption","level":3,"score":0.7486097812652588},{"id":"https://openalex.org/C2781231759","wikidata":"https://www.wikidata.org/wiki/Q58184","display_name":"Nephron","level":3,"score":0.7085068821907043},{"id":"https://openalex.org/C149011108","wikidata":"https://www.wikidata.org/wiki/Q652985","display_name":"Transporter","level":3,"score":0.6974779367446899},{"id":"https://openalex.org/C161573976","wikidata":"https://www.wikidata.org/wiki/Q420277","display_name":"Glucose transporter","level":3,"score":0.6834456920623779},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.574590802192688},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5280854105949402},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5092548131942749},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5076218843460083},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5019192695617676},{"id":"https://openalex.org/C2780222010","wikidata":"https://www.wikidata.org/wiki/Q2916078","display_name":"Proximal tubule","level":3,"score":0.4863594174385071},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46202903985977173},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.43145132064819336},{"id":"https://openalex.org/C57476199","wikidata":"https://www.wikidata.org/wiki/Q7312501","display_name":"Renal sodium reabsorption","level":4,"score":0.4229433238506317},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.40680375695228577},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.2854497730731964},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.24050533771514893},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2389173754","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTotal-SWCX200913053.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764952023","display_name":"Xiandai shengwu yixue jinzhan","issn_l":"1673-6273","issn":["1673-6273"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4361727479","host_organization_name":"Heilongjiang Red Cross Society","host_organization_lineage":["https://openalex.org/P4361727479"],"host_organization_lineage_names":["Heilongjiang Red Cross Society"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Xiandai shengwu yixue jinzhan","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2358722927","https://openalex.org/W2357014648","https://openalex.org/W2412384811","https://openalex.org/W2361043782","https://openalex.org/W2084036084","https://openalex.org/W2347924439","https://openalex.org/W2116771437","https://openalex.org/W1970063460","https://openalex.org/W2392830874","https://openalex.org/W2186788635"],"abstract_inverted_index":{"Sodium-glucose":[0],"co-transporters(SGLT)":[1],"are":[2],"a":[3,34,47],"family":[4],"of":[5,13,21,60,69,92,101,105,111],"glucose":[6,29,53,76],"transporter":[7],"found":[8],"in":[9,42,51,55],"the":[10,14,18,22,43,56,79,90,99],"intestinal":[11],"mucosa":[12],"small":[15],"intestine(SGLT)":[16],"and":[17,24,45,108,117],"proximal":[19,57],"tubule":[20],"nephron(SGLT2":[23],"SGLT1).They":[25],"contribute":[26],"to":[27],"renal":[28,52],"reabsorption.The":[30],"sodium-glucose":[31],"co-transporter-2(SGLT2)":[32],"is":[33,39,62],"low-affinity":[35],"transport":[36],"system":[37],"that":[38],"specifically":[40],"expressed":[41],"kidney":[44],"play":[46],"very":[48],"important":[49],"role":[50],"reabsorption":[54],"tubule.Selective":[58],"inhibition":[59],"SGLT2":[61,87,102,113],"an":[63],"innovative":[64],"therapeutic":[65],"strategy":[66],"for":[67,89],"treatment":[68,91],"type":[70,93],"2":[71,94],"diabetes":[72,95],"patients":[73],"by":[74],"enhancing":[75],"loss":[77],"through":[78],"urine.In":[80],"this":[81],"paper,the":[82],"latest":[83],"research":[84,116],"progress":[85],"on":[86],"inhibitors":[88,114],"were":[96],"introduced.We":[97],"emphasized":[98],"mechanism":[100],"inhibitors,the":[103],"data":[104],"biological":[106],"activities":[107],"clinical":[109],"trials":[110],"some":[112],"under":[115],"development.":[118]},"counts_by_year":[],"updated_date":"2025-10-10T17:16:08.811792","created_date":"2016-06-24T00:00:00"}